T-cell epitope peptides

Details T-cell epitope peptides T-cell epitope peptides

2008-06-27

2009-06-16

Huynh, Phuong (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S275100, C530S326000, C530S327000, C530S328000

Reexamination Certificate

active

07547440

ABSTRACT:
The T-cell epitope site on a Japanese cypress (hinoki) pollen allergen molecule has been identified by stimulating a T-cell line established from a patient suffering from Japanese cypress pollen allergy with an overlap peptide covering the primary structure of the Japanese cypress pollen allergen. The peptide is useful in peptide-based immunotherapy for patients with spring tree pollinosis including patients with Japanese cypress pollinosis having cross reactivity with Japanese cypress pollen. The peptide is also useful for diagnosing spring tree pollinosis.

REFERENCES:
patent: 6719976 (2004-04-01), Sone et al.
patent: 7112329 (2006-09-01), Kino et al.
patent: 7407657 (2008-08-01), Kino et al.
patent: 0 655 500 (1995-05-01), None
patent: 0 714 662 (1996-06-01), None
patent: 0 923 940 (1999-06-01), None
patent: 03-275699 (1991-12-01), None
patent: 03-284697 (1991-12-01), None
patent: 06-500308 (1994-01-01), None
patent: 06-508994 (1994-10-01), None
patent: 05-507700 (1994-11-01), None
patent: 07-503362 (1995-04-01), None
patent: 07-118295 (1995-05-01), None
patent: A HEI 8-47392 (1996-02-01), None
patent: 8-502163 (1996-03-01), None
patent: 08-127591 (1996-05-01), None
patent: 08-505284 (1996-06-01), None
patent: 8 176192 (1996-07-01), None
patent: 08-333391 (1996-12-01), None
patent: P3474898 (2003-12-01), None
patent: 05-15427 (2005-05-01), None
patent: 3734040 (2006-01-01), None
patent: WO93/01213 (1993-01-01), None
patent: WO 93/08280 (1993-04-01), None
patent: WO 93/19178 (1993-09-01), None
patent: WO 94/01560 (1994-01-01), None
patent: WO94/11512 (1994-05-01), None
patent: WO 94/11512 (1994-05-01), None
patent: WO 95/27786 (1995-10-01), None
patent: WO97/32600 (1997-12-01), None
Berzofsky et al., in Fundamental Immunology 2ndedition, Raven Press, 1989.
Burks et al., Eur. J. Biochem., 245 :334-339 (1997).
Fasier et al., J Allergy Clin Immunology 101(4): 521-530, Apr. 1998.
Hoyne et al., Immunol and Cell Biology 74 : 180-186 (1996).
Ide et al., Allergy no Rinshou 11(3):174-178 (1991).
Ikagawa et al., “Allergens, IgE, mediators, inflammatory mechanisms . . . ” J. Allergy Clin. Immunol., 97 :53-64 (1996).
Ikagawa et al., Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1) derived peptide induced alterations in human T cell responses and T cell receptor antagonism, J Allergy Clin Immunol, 97(1 pt 1):53-64, Jan. 1996.
Matsushita et al., “Allele Specificity of Structural Requirement for Peptides . . . Syndrome,” J. Exp. Med., 189:873-883 (1994).
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Okano et al., Allergy 43(9):1179-1184 (1994).
Saito et al., Chiryo 78(2):1571-1576 (1996).
Stanley et al., Archives of Biochemistry and Biophysics, 342(2): 244-253, Jun. 1997.
Stryer et al., in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33 (1998).
Suzuki et al., Mol. Immunol., 33(4-5):451-60 (1996).
Swoboda et al., “Isoforms of Bet v 1, the Major Birch Pollen Allergen, Analyzed by Liquid Chromatography, Mass Spectrometry, and cDNA Cloning,” J. Biol. Chem., 270(6):2607-2613 (1995).
Taniai et al., “epitopes on Cry j I and Cry j II for the Human IgE antibodies Cross-Reactive . . . Pollen,” Mol. Immunol. 30(2):183-189 (1993).
Tokyo Jikeikai Ika Daigaku Zasshi, 111(6):949-956 (1996).
Webster's II New Riverside University Dictionary, p. 933, 1984.
Devlin et al., “Random Peptide Libraries: A Source of Specific Protein Binding Molecules”, Science, 249:404-406 (Jul. 1990).

Affiliated with

Also associated with

Rating

T-cell epitope peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with T-cell epitope peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T-cell epitope peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4092360